Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to cardiovascular
disease (CVD). The aim of this study is to assess whether and to what extent the excess risk …

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide
and may confer increased cardiometabolic risk with consequent adverse cardiovascular …

Background Inflammatory cytokines have been considered to be significant factors
contributing to the development and progression of non-alcoholic fatty liver disease …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Components of metabolic syndrome increase the risk of mortal... : Medicine Components of
metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) …

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) and cardiovascular
diseases (CVDs) have common metabolic risk factors. Despite reports from clinical studies …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Excessive accumulation of triglycerides (TG) in liver, in the absence of significant alcohol
consumption is nonalcoholic fatty liver disease (NAFLD). NAFLD is a significant risk factor …

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of
chronic liver disease, and its prevalence is much higher in obese individuals. NAFLD is …

Non-alcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese subjects;
however, it is not rare among lean individuals. Given the absence of traditional risk factors, it …